• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Timber Pharmaceuticals Inc (NY: TMBR )

    N/A UNCHANGED
    Last Price Updated: 8:00 PM EST, Nov 28, 2023 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Timber Pharmaceuticals Inc

    < Previous 1 2 3 4 5 Next >
    Timber Pharmaceuticals Receives Court Approval of All First Day Motions to Support Business Operations & Discloses Communication From NYSE American
    Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
    Via NewMediaWire
    Timber Pharmaceuticals Announces NYSE Acceptance of Plan to Regain Listing Compliance
    Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
    Via NewMediaWire
    TIMBER PHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Timber Pharmaceuticals, Inc. - TMBR
    From Kahn Swick & Foti, LLC
    Via Business Wire
    Benzinga's Top Ratings Upgrades, Downgrades For August 28, 2023
    Via Benzinga
    Crude Oil Falls; Nikola Shares Plummet
    U.S. stocks traded mixed toward the end of trading, with the Nasdaq Composite gaining around 1.5% on Monday. The Dow traded down 0.16% to 34,446.91 while the NASDAQ rose 1.52% to 13,492.73. The S&P... 
    Via Benzinga
    Topics Stocks
    Exposures Fossil Fuels US Equities
    Why Super League Gaming Are Trading Lower By Around 46%? Here Are Other Stocks Moving In Monday's Mid-Day Session
    Gainers China SXT Pharmaceuticals, Inc. (NASDAQ: SXTC) shares jumped 120% to $0.33. 
    Via Benzinga
    12 Health Care Stocks Moving In Monday's Intraday Session
    Via Benzinga
    Why Timber Pharmaceuticals Stock Is Skyrocketing Today
    Timber Pharmaceuticals, Inc. (NYSE: TMBR) has  
    Via Benzinga
    Dow Tumbles Over 100 Points; Timber Pharmaceuticals Shares Spike Higher
    U.S. stocks traded mixed midway through trading, with the Dow Jones falling more than 100 points on Monday. The Dow traded down 0.40% to 34,362.93 while the NASDAQ rose 0.78% to 13,394.60. The S&P 500,... 
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    TMBR Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Timber Pharmaceuticals, Inc. Is Fair to Shareholders
    From Halper Sadeh LLC
    Via Business Wire
    Why Is Skillz (SKLZ) Stock Up 20% Today?
    Skillz (SKLZ) stock is taking off on Monday after the mobile gaming company announced plans for a share repurchase program. 
    Via InvestorPlace
    Why Is Timber Pharmaceuticals (TMBR) Stock Up 96% Today?
    Timber Pharmaceuticals (TMBR) stock is undergoing a rally on Monday after announcing that Leo US is acquiring it in a $36 million deal. 
    Via InvestorPlace
    US Stocks Mostly Higher; Nasdaq Jumps 100 Points
    U.S. stocks traded mostly higher this morning, with the Nasdaq Composite gaining more than 100 points on Monday. Following the market opening Monday, the Dow traded down 0.11% to 34,461.22 while the... 
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    12 Health Care Stocks Moving In Monday's Pre-Market Session
    Via Benzinga
    Timber Pharmaceuticals to be Acquired by LEO Pharma
    Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
    Via NewMediaWire
    12 Health Care Stocks Moving In Friday's After-Market Session
    Via Benzinga
    12 Health Care Stocks Moving In Friday's Pre-Market Session
    Via Benzinga
    Timber Pharmaceuticals Discloses Communication From NYSE American
    Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
    Via NewMediaWire
    Timber Pharmaceuticals to Present Interim Analyses from Phase 3 ASCEND Study of TMB-001 in Congenital Ichthyosis
    Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
    Via NewMediaWire
    12 Health Care Stocks Moving In Tuesday's Pre-Market Session
    Via Benzinga
    Why Bluejay Diagnostics Shares Are Trading Lower By 12%; Here Are 20 Stocks Moving Premarket
    Gainers Visionary Education Technology Holdings Group Inc. (NASDAQ: VEDU) shares rose 85.8% to $0.7985 in pre-market trading. 
    Via Benzinga
    Dow Drops Over 100 Points; Crude Oil Rises
    U.S. stocks traded mixed toward the end of trading, with Dow Jones dropping over 100 points on Monday. The Dow traded down 0.33% to 33,651.23 while the NASDAQ rose 0.30% to 13,279.88. The S&P 500, also... 
    Via Benzinga
    12 Health Care Stocks Moving In Monday's Intraday Session
    Via Benzinga
    Why Amedisys Shares Are Trading Higher By 14%? Here Are Other Stocks Moving In Monday's Mid-Day Session
    Gainers Sono Group N.V. (NYSE: SEV) shares surged 152.7% to $0.4367. Sono Group applied to Insolvency Court of Munich, Germany, to permit opening of self-administration proceeding. 
    Via Benzinga
    Nasdaq Rises 70 Points; ISM Services PMI Drops In May
    U.S. stocks traded mixed midway through trading, with Nasdaq Composite gaining around 70 points on Monday. The Dow traded down 0.21% to 33,691.13 while the NASDAQ rose 0.54% to 13,312.65. The S&P 500,... 
    Via Benzinga
    Timber Pharmaceuticals’ (NYSE American: TMBR) Phase 3 ASCEND Study for TMB-001: A Leap Forward in Congenital Ichthyosis Treatment
    Significant Progress in Timber Pharmaceuticals' Phase 3 ASCEND Study Timber Pharmaceuticals (NYSE American: TMBR), a clinical-stage biopharmaceutical company specializing in 
    Via Spotlight Growth
    Exposures Product Safety
    12 Health Care Stocks Moving In Monday's Pre-Market Session
    Via Benzinga
    Why Are Timber Pharmaceuticals Shares Trading Higher Today
    The FDA has granted dermal carcinogenicity (CARC) waiver for Timber Pharmaceuticals Inc's (NYSE: TMBR) TMB-001, a topical isotretinoin formulated using the company's patented IPEG delivery system.  
    Via Benzinga
    Timber Pharmaceuticals Announces FDA Grant of CARC Waiver for TMB-001
    Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
    Via NewMediaWire
    Exposures Product Safety
    Timber Pharmaceuticals Provides Business Update and Announces First Quarter 2023 Financial Results
    Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
    Via NewMediaWire
    < Previous 1 2 3 4 5 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.